Research to inform the care of neurologically deceased organ donors is complicated by a lack of standards for research consent. In this systematic review, we aim to describe current practices of soliciting consent for participation in prospective studies of neurologically deceased donors, including the frequency and justification for these various models of consent. Among the 74 studies included, 14 did not report on any regulatory review, and 13 did not report on the study consent procedures. Of the remaining 47 studies, 24 utilized a waiver of research consent. The most common justification for a waiver of research consent related to the fact that neurologically deceased donors are not considered human subjects. In conclusion, among studies of neurologically deceased donors, research consent models vary and are inconsistently reported. Consensus and standardization in the application of research consent models will help to advance this emerging field of research.
AbtP. L.MarshC. L.DunnT. B.HewittW. R.RodrigueJ. R.HamJ. M.FengS. (2013). Challenges to research and innovation to optimize deceased donor organ quality and quantity. American Journal of Transplantation, 13(6), 1400–1404. https://doi.org/10.1111/ajt.12243
2.
BloomM. B.RazaS.BhaktaA.EwingT.PatelM.LeyE. J.. . . MalinoskiD. (2015). Impact of deceased organ donor demographics and critical care end points on liver transplantation and graft survival rates. Journal of the American College of Surgeons, 220(1), 38–47. https://doi.org/10.1016/j.jamcollsurg.2014.09.020
Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and Social Sciences and Humanities Research Council of Canada. (2014, December). Tri-council policy statement: Ethical conduct for research involving humans. http://www.pre.ethics.gc.ca/eng/documents/tcps2-2018-en-interactive-final.pdf
5.
ChasséM.GlenP.DoyleM. A.McIntyreL.EnglishS. W.KnollG.. . . FergussonD. A. (2013). Ancillary testing for diagnosis of brain death: A protocol for a systematic review and meta-analysis. Systematic Reviews, 2, 100. https://doi.org/10.1186/2046-4053-2-100
6.
ChenS.Selamet TierneyE. S.KhushK. K.NguyenJ.GoldsteinB. A.MayL. J.. . . RosenthalD. N. (2015). Reliability of echocardiographic measurements of left ventricular systolic function in potential pediatric heart transplant donors. Journal of Heart and Lung Transplantation, 34(1), 100–106. https://doi.org/10.1016/j.healun.2014.08.019
7.
CinottiR.RoquillyA.MahéP. J.FeuilletF.YehiaA.BelliardG.. . . AsehnouneK. (2014). Pulse pressure variations to guide fluid therapy in donors: A multicentric echocardiographic observational study. Journal of Critical Care, 29(4), 489–494. https://doi.org/10.1016/j.jcrc.2014.03.027
8.
de la CruzJ. S.SallyM. B.ZatarainJ. R.CrutchfieldM.RamseyK.NielsenJ.. . . MalinoskiD. J. (2015). The impact of blood transfusions in deceased organ donors on the outcomes of 1,884 renal grafts from United Network for Organ Sharing Region 5. Journal of Trauma and Acute Care Surgery, 79(4Suppl. 2), S164–S170. https://doi.org/10.1097/TA.0000000000000670
9.
DikdanG. S.Mora-EstevesC.KoneruB. (2012). Review of randomized clinical trials of donor management and organ preservation in deceased donors: Opportunities and issues. Transplantation, 94(5), 425–441. https://doi.org/10.1097/TP.0b013e3182547537
10.
EyraudD.Ben AyedS.TanguyM. L.VézinetC.SiksikJ. M.BernardM.. . . HannounL. (2008). Procalcitonin in liver transplantation: Are high levels due to donors or recipients?Critical Care, 12(4), Article R85. https://doi.org/10.1186/cc6942
11.
FengS. (2010). Donor intervention and organ preservation: Where is the science and what are the obstacles?American Journal of Transplantation, 10(5), 1155–1162. https://doi.org/10.1111/j.1600-6143.2010.03100.x
12.
GlazierA. K.HeffernanK. G.RodrigueJ. R. (2015). A framework for conducting deceased donor research in the United States. Transplantation, 99(11), 2252–2257. https://doi.org/10.1097/tp.0000000000000841
LevveyB. J.WestallG. P.KotsimbosT.WilliamsT. J.SnellG. I. (2008). Definitions of warm ischemic time when using controlled donation after cardiac death lung donors. Transplantation, 86(12), 1702–1706. https://doi.org/10.1097/TP.0b013e3181901f24
15.
MalinoskiD. J.PatelM. S.AhmedO.DalyM. C.MooneyS.GraybillC. O.. . . SalimA. (2013). The impact of meeting donor management goals on the development of delayed graft function in kidney transplant recipients. American Journal of Transplantation, 13(4), 993–1000. https://doi.org/10.1111/ajt.12090
16.
MasciaL.PaseroD.SlutskyA. S.ArguisM. J.BerardinoM.GrassoS.. . . RanieriV. M. (2010). Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: A randomized controlled trial. Journal of the American Medical Association, 304(23), 2620–2627. https://doi.org/10.1001/jama.2010.1796
17.
MeyfroidtG.GunstJ.Martin-LoechesI.SmithM.RobbaC.TacconeF. S.CiterioG. (2019). Management of the brain-dead donor in the ICU: General and specific therapy to improve transplantable organ quality. Intensive Care Medicine, 45(3), 343–353. https://doi.org/10.1007/s00134-019-05551-y
18.
MoneT.HeldensJ.NiemannC. U. (2013). Deceased organ donor research: The last research frontier?Liver Transplantation, 19(2), 118–121. https://doi.org/10.1002/lt.23579
19.
MullerL.Nicolas-RobinA.BastideS.MartinezO.LouartG.ColavolpeJ. C.. . . RiouB. (2015). Assessment of neutrophil gelatinase-associated lipocalin in the brain-dead organ donor to predict immediate graft function in kidney recipients: A prospective, multicenter study. Anesthesiology, 122(1), 96–105. https://doi.org/10.1097/ALN.0000000000000497
20.
National Academies of Sciences, Engineering, and Medicine. (2017). Opportunities for organ donor intervention research: Saving lives by improving the quality and quantity of organs for transplantation (J. F.ChildressS.DomnitzC. T.LivermanS.Domnitz, Eds.). The National Academies Press. https://doi.org/10.17226/24884.
Nicolas-RobinA.SalviN.MedimaghS.AmourJ.Le ManachY.CoriatP.. . . LangeronO. (2007). Combined measurements of N-terminal pro-brain natriuretic peptide and cardiac troponins in potential organ donors. Intensive Care Medicine, 33(6), 986–992. https://doi.org/10.1007/s00134-007-0601-7
24.
NiemannC. U.FeinerJ.SwainS.BuntingS.FriedmanM.CrutchfieldM.. . . MalinoskiD. (2015). Therapeutic hypothermia in deceased organ donors and kidney-graft function. New England Journal of Medicine, 373(5), 405–414. https://doi.org/10.1056/NEJMoa1501969
OrbanJ.-C.FontaineE.CassutoE.BaumstarckK.LeoneM.ConstantinJ.-M.IchaiC. (2018). Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): Study protocol for a randomized controlled trial. Trials, 19(1), 231. https://doi.org/https://doi.org/10.1186/s13063-018-2597-4
27.
PinsardM.RagotS.MertesP. M.BleichnerJ. P.ZitouniS.CookF.. . . PichonN. (2014). Interest of low-dose hydrocortisone therapy during brain-dead organ donor resuscitation: The CORTICOME study. Critical Care, 18(4), Article R158. https://doi.org/10.1186/cc13997
28.
Protection of Human Subjects, 21 C.F.R, § 50.3(g). (2018).
29.
RodrigueJ. R.FengS.JohanssonA. C.GlazierA. K.AbtP. L. (2016). Deceased donor intervention research: A survey of transplant surgeons, organ procurement professionals, and institutional review board members. American Journal of Transplantation, 16(1), 278–286. https://doi.org/10.1111/ajt.13482
30.
RudgeC.MatesanzR.DelmonicoF. L.ChapmanJ. (2012). International practices of organ donation. British Journal of Anaesthesia, 108(Suppl. 1), i48–i55. https://doi.org/10.1093/bja/aer399
31.
SallyM. B.EwingT.CrutchfieldM.PatelM. S.RazaS.De La CruzS.. . . MalinoskiD. J. (2014). Determining optimal threshold for glucose control in organ donors after neurologic determination of death: A United Network for Organ Sharing Region 5 Donor Management Goals Workgroup prospective analysis. Journal of Trauma and Acute Care Surgery, 76(1), 62–68; discussion 68–69. https://doi.org/10.1097/TA.0b013e3182ab0d9b
SuntharalingamC.SharplesL.DudleyC.BradleyJ. A.WatsonC. J. (2009). Time to cardiac death after withdrawal of life-sustaining treatment in potential organ donors. American Journal of Transplantation, 9(9), 2157–2165. https://doi.org/10.1111/j.1600-6143.2009.02758.x
34.
van BeinumA.HornbyL.DhananiS.WardR.Chambers-EvansJ.MenonK. (2017). Feasibility of conducting prospective observational research on critically ill, dying patients in the intensive care unit. Journal of Medical Ethics, 43(1), 47–51. https://doi.org/10.1136/medethics-2016-103683
35.
WareL. B.KoyamaT.BillheimerD.LandeckM.JohnsonE.BradyS.. . . MatthayM. A. (2011). Advancing donor management research: Design and implementation of a large, randomized, placebo-controlled trial. Annals of Intensive Care, 1(1), 20. https://doi.org/10.1186/2110-5820-1-20
36.
WindJ.SnoeijsM. G.BrugmanC. A.VerveldeJ.ZwavelingJ.van MookW. N.van HeurnE. L. (2012). Prediction of time of death after withdrawal of life-sustaining treatment in potential donors after cardiac death. Critical Care Medicine, 40(3), 766–769. https://doi.org/10.1097/CCM.0b013e318232e2e7
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
